BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 15768565)

  • 1. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluorocarbon-based oxygen delivery.
    Riess JG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):567-80. PubMed ID: 17090429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N; Mehra A
    ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a 3D volume 19F MR imaging protocol for mapping oxygen tension (pO2) in perfluorocarbons at low field.
    Pratt RG; Zheng J; Stewart BK; Shiferaw Y; McGoron AJ; Samaratunga RC; Thomas SR
    Magn Reson Med; 1997 Feb; 37(2):307-13. PubMed ID: 9001157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorocarbon-based oxygen carriers: review of products and trials.
    Castro CI; Briceno JC
    Artif Organs; 2010 Aug; 34(8):622-34. PubMed ID: 20698841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):805-18. PubMed ID: 1391515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange.
    Johnson JL; Dolezal MC; Kerschen A; Matsunaga TO; Unger EC
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(4):156-62. PubMed ID: 19548131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A second-generation blood substitute (perflubron emulsion) increases the blood solubility of modern volatile anesthetics in vitro.
    Cuignet OY; Baele PM; Van Obbergh LJ
    Anesth Analg; 2002 Aug; 95(2):368-72, table of contents. PubMed ID: 12145053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of semifluorinated alkanes in blood-substitutes.
    Meinert H; Knoblich A
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):583-95. PubMed ID: 8117848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical potential of intravenously administered perfluorocarbons.
    Habler O; Kleen M; Messmer K
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro model to compare the oxygen offloading behaviour of dodecafluoropentane emulsion (DDFPe).
    Jayaraman MS; Graham K; Unger EC
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):783-789. PubMed ID: 30873883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluorocarbon-based oxygen carriers: from physics to physiology.
    Jägers J; Wrobeln A; Ferenz KB
    Pflugers Arch; 2021 Feb; 473(2):139-150. PubMed ID: 33141239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative assessment of phospholipid-stabilized perfluorocarbon-based blood substitutes.
    Tarara TE; Malinoff SH; Pelura TJ
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1287-93. PubMed ID: 7849935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the influence of the aqueous phase bioconstituent environment on the F-19 T1 of perfluorocarbon blood substitute emulsions.
    Thomas SR; Pratt RG; Millard RW; Samaratunga RC; Shiferaw Y; Clark LC; Hoffmann RE
    J Magn Reson Imaging; 1994; 4(4):631-5. PubMed ID: 7949694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part I: oxygen uptake in tubular vessels.
    Patel S; Mehra A
    ASAIO J; 1998; 44(3):144-56. PubMed ID: 9617943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen solubility, rheology and hemodynamics of perfluorocarbon emulsion blood substitutes.
    Millard RW
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):235-44. PubMed ID: 8087245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the perfluorocarbon emulsions of second generation.
    Meinert H; Fackler R; Knoblich A; Mader J; Reuter P; Röhlke W
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(1):95-113. PubMed ID: 1617088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfluorocarbons in Research and Clinical Practice: A Narrative Review.
    Nocentini G; MacLaren G; Bartlett R; De Luca D; Perdichizzi S; Stoppa F; Marano M; Cecchetti C; Biasucci DG; Polito A; AlGhobaishi A; Guner Y; Gowda SH; Hirschl RB; Di Nardo M
    ASAIO J; 2023 Dec; 69(12):1039-1048. PubMed ID: 37549675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluorocarbon emulsions and cardiopulmonary bypass: a technique for the future.
    Spiess BD; Cochran RP
    J Cardiothorac Vasc Anesth; 1996 Jan; 10(1):83-89; quiz 89-90. PubMed ID: 8634391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rheological behavior of blood substitutes with a perfluorocarbon base].
    Draffehn J; Reichelt H
    Pharmazie; 1991 Nov; 46(11):800-2. PubMed ID: 1725823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.